J. Alexieva-Figusch

1.4k total citations
30 papers, 1.1k citations indexed

About

J. Alexieva-Figusch is a scholar working on Oncology, Genetics and Cancer Research. According to data from OpenAlex, J. Alexieva-Figusch has authored 30 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 18 papers in Genetics and 7 papers in Cancer Research. Recurrent topics in J. Alexieva-Figusch's work include Estrogen and related hormone effects (18 papers), Cancer Treatment and Pharmacology (11 papers) and HER2/EGFR in Cancer Research (9 papers). J. Alexieva-Figusch is often cited by papers focused on Estrogen and related hormone effects (18 papers), Cancer Treatment and Pharmacology (11 papers) and HER2/EGFR in Cancer Research (9 papers). J. Alexieva-Figusch collaborates with scholars based in Netherlands, Switzerland and Finland. J. Alexieva-Figusch's co-authors include Henk Portengen, John A. Foekens, J.G.M. Klijn, W L van Putten, Wim L.J. van Putten, Marinus A. Blankenstein, Jean Claude Reubi, J.G.M. Klijn, Anita M.A.C. Trapman and C. J. Rodenburg and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Breast Cancer Research and Treatment.

In The Last Decade

J. Alexieva-Figusch

30 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Alexieva-Figusch Netherlands 15 596 516 330 326 200 30 1.1k
Ulla Johansson Sweden 16 598 1.0× 261 0.5× 272 0.8× 493 1.5× 68 0.3× 21 1.1k
Nigel Sacks United Kingdom 18 521 0.9× 466 0.9× 268 0.8× 590 1.8× 135 0.7× 37 1.2k
Audrey Barlock United States 12 487 0.8× 451 0.9× 207 0.6× 380 1.2× 53 0.3× 13 1.0k
Mika K. Derynck United States 15 553 0.9× 331 0.6× 648 2.0× 281 0.9× 121 0.6× 34 1.5k
Lars Ottestad Norway 15 1.2k 2.1× 583 1.1× 488 1.5× 517 1.6× 62 0.3× 35 1.7k
Robert B. Dickson United States 10 475 0.8× 280 0.5× 482 1.5× 122 0.4× 118 0.6× 11 902
Chiyomi Egawa Japan 20 628 1.1× 471 0.9× 740 2.2× 302 0.9× 49 0.2× 69 1.4k
Françoise Descôtes France 20 342 0.6× 119 0.2× 593 1.8× 326 1.0× 213 1.1× 66 1.2k
Purna A. Joshi Canada 11 901 1.5× 348 0.7× 764 2.3× 324 1.0× 42 0.2× 13 1.4k
S. Johnston United Kingdom 18 508 0.9× 371 0.7× 265 0.8× 262 0.8× 35 0.2× 50 923

Countries citing papers authored by J. Alexieva-Figusch

Since Specialization
Citations

This map shows the geographic impact of J. Alexieva-Figusch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Alexieva-Figusch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Alexieva-Figusch more than expected).

Fields of papers citing papers by J. Alexieva-Figusch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Alexieva-Figusch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Alexieva-Figusch. The network helps show where J. Alexieva-Figusch may publish in the future.

Co-authorship network of co-authors of J. Alexieva-Figusch

This figure shows the co-authorship network connecting the top 25 collaborators of J. Alexieva-Figusch. A scholar is included among the top collaborators of J. Alexieva-Figusch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Alexieva-Figusch. J. Alexieva-Figusch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Klijn, Jan G.M., Maxime P. Look, Henk Portengen, et al.. (1994). The prognostic value of epidermal growth factor receptor (EGF-R) in primary breast cancer: Results of a 10 year follow-up study. Breast Cancer Research and Treatment. 29(1). 73–83. 101 indexed citations
2.
Klijn, J.G.M., P.M.J.J. Berns, Wim L.J. van Putten, et al.. (1993). Critical Review of Growth Factors as Clinical Tools in Primary and Metastatic Breast Cancer. Recent results in cancer research. 127. 77–88. 2 indexed citations
3.
Klijn, J.G.M., P.M.J.J. Berns, M. Bontenbal, J. Alexieva-Figusch, & John A. Foekens. (1992). Clinical breast cancer, new developments in selection and endocrine treatment of patients. The Journal of Steroid Biochemistry and Molecular Biology. 43(1-3). 211–221. 37 indexed citations
4.
Bontenbal, M., A.S.T. Planting, C. J. Rodenburg, et al.. (1992). Weekly low-dose mitoxantrone plus doxorubicin as second-line chemotherapy for advanced breast cancer. Breast Cancer Research and Treatment. 21(2). 133–138. 5 indexed citations
5.
Gaast, Ate van der, J. Alexieva-Figusch, Charles J. Vecht, Jaap Verweij, & G. Stoter. (1990). Complete Remission of a Brain Metastasis to Third-Line Hormonal Treatment with Megestrol Acetate. American Journal of Clinical Oncology. 13(6). 507–509. 18 indexed citations
6.
Foekens, John A., Wim L.J. van Putten, Henk Portengen, et al.. (1990). Prognostic value of pS2 protein and receptors for epidermal growth factor (EGF-R), Insulin-like growth factor-1 (IGF-1-R) and somatostatin (SS-R) in patients with breast and ovarian cancer. The Journal of Steroid Biochemistry and Molecular Biology. 37(6). 815–821. 52 indexed citations
7.
Verweij, Jaco J., P.C. de Jong, P.H.M. de Mulder, et al.. (1989). Induction Chemotherapy with Cisplatin and Continuous Infusion 5-Fluorouracil in Locally Far-Advanced Head and Neck Cancer. American Journal of Clinical Oncology. 12(5). 420–424. 12 indexed citations
8.
9.
Verweij, Jaco J., et al.. (1988). Ifosfamide in advanced head and neck cancer. A phase II study of the Rotterdam cooperative head and neck cancer study group. European Journal of Cancer and Clinical Oncology. 24(4). 795–796. 16 indexed citations
10.
Alexieva-Figusch, J., et al.. (1987). Endocrine effects of aminoglutethimide plus hydrocortisone versus effects of high dose of hydrocortisone alone in postmenopausal metastatic breast cancer. European Journal of Cancer and Clinical Oncology. 23(9). 1349–1356. 8 indexed citations
11.
12.
Alexieva-Figusch, J., et al.. (1986). [Prognostic factors in thyroid carcinoma: follow-up findings in 429 patients].. PubMed. 130(16). 731–6. 4 indexed citations
13.
Alexieva-Figusch, J., et al.. (1985). Orchidectomy and oestrogens as secondary forms of treatment for metastatic prostatic cancer.. PubMed. 185A. 335–49. 3 indexed citations
14.
Alexieva-Figusch, J., et al.. (1985). Tamoxifen therapy in premenopausal women with metastatic breast cancer.. PubMed. 69(4). 363–8. 19 indexed citations
15.
Alexieva-Figusch, J., et al.. (1985). Sequential treatment of metastatic breast cancer with tamoxifen after megestrol acetate therapy and vice versa (a retrospective study). Medical Oncology and Tumor Pharmacotherapy. 2(2). 69–75. 9 indexed citations
16.
Alexieva-Figusch, J., Marinus A. Blankenstein, W. C. J. Hop, et al.. (1984). Treatment of metastatic breast cancer patients with different dosages of megestrol acetate; dose relations, metabolic and endocrine effects. European Journal of Cancer and Clinical Oncology. 20(1). 33–40. 62 indexed citations
17.
Alexieva-Figusch, J., Marinus A. Blankenstein, Frank H. de Jong, & S. W. J. Lamberts. (1984). Endocrine effects of the combination of megestrol acetate and tamoxifen in the treatment of metastatic breast cancer. European Journal of Cancer and Clinical Oncology. 20(9). 1135–1140. 14 indexed citations
18.
Alexieva-Figusch, J.. (1984). Megestrol acetate in the treatment of metastatic breast cancer. Data Archiving and Networked Services (DANS). 1 indexed citations
19.
Henkelman, M.S., et al.. (1980). Estrogen, androgen, glucocorticoid, and progesterone receptors in progestin-induced regression of human breast cancer.. PubMed. 40(7). 2557–61. 94 indexed citations
20.
Alexieva-Figusch, J., et al.. (1975). 23. High affinity binding of glucocorticoids, estrogens and androgens in cytosols of human mammary carcinomas. Journal of Steroid Biochemistry. 6(11-12). xv–xv. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ulla Johansson Breakdown of academic impact, for papers by Nigel Sacks Breakdown of academic impact, for papers by Audrey Barlock Breakdown of academic impact, for papers by Mika K. Derynck Breakdown of academic impact, for papers by Lars Ottestad Breakdown of academic impact, for papers by Robert B. Dickson Breakdown of academic impact, for papers by Chiyomi Egawa Breakdown of academic impact, for papers by Françoise Descôtes Breakdown of academic impact, for papers by Purna A. Joshi Breakdown of academic impact, for papers by S. Johnston
Rankless by CCL
2026